Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRSP NYSE:NIO NYSE:TWLO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRSPCRISPR Therapeutics$53.99-0.7%$52.84$44.12▼$78.48$5.24B1.741.62 million shs1.53 million shsNIONIO$5.09+0.8%$5.83$3.38▼$8.02$12.54B0.9235.02 million shs34.29 million shsTWLOTwilio$184.49+0.5%$182.39$91.84▼$238.48$27.87B1.392.72 million shs2.06 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRSPCRISPR Therapeutics-0.68%+3.79%+7.21%+14.65%+18.53%NIONIO+0.49%+1.50%-2.40%-12.00%+48.40%TWLOTwilio+0.58%-4.23%-1.84%+47.25%+56.65%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRSPCRISPR Therapeutics$53.99-0.7%$52.84$44.12▼$78.48$5.24B1.741.62 million shs1.53 million shsNIONIO$5.09+0.8%$5.83$3.38▼$8.02$12.54B0.9235.02 million shs34.29 million shsTWLOTwilio$184.49+0.5%$182.39$91.84▼$238.48$27.87B1.392.72 million shs2.06 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRSPCRISPR Therapeutics-0.68%+3.79%+7.21%+14.65%+18.53%NIONIO+0.49%+1.50%-2.40%-12.00%+48.40%TWLOTwilio+0.58%-4.23%-1.84%+47.25%+56.65%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRSPCRISPR Therapeutics 2.58Moderate Buy$67.7825.54% UpsideNIONIO 2.36Hold$6.7031.63% UpsideTWLOTwilio 2.88Moderate Buy$198.247.45% UpsideCurrent Analyst Ratings BreakdownLatest NIO, TWLO, and CRSP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026TWLOTwilio The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy6/18/2026TWLOTwilio Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$230.006/12/2026CRSPCRISPR Therapeutics UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$80.006/11/2026TWLOTwilio Tigress FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$170.00 ➝ $255.006/11/2026CRSPCRISPR Therapeutics Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetEqual Weight$60.006/11/2026TWLOTwilio Tigress FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$170.00 ➝ $255.006/1/2026TWLOTwilio TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/27/2026CRSPCRISPR Therapeutics CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Outperform5/22/2026NIONIO Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Perform$6.005/21/2026NIONIO Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$6.805/18/2026TWLOTwilio OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$200.00 ➝ $235.00(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRSPCRISPR Therapeutics$3.51M1,483.57N/AN/A$20.17 per share2.68NIONIO$12.51B1.01N/AN/A$0.24 per share21.21TWLOTwilio$5.07B5.53$6.53 per share28.24$51.32 per share3.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRSPCRISPR Therapeutics-$581.60M-$6.22N/AN/AN/A-13,856.54%-25.66%-20.39%8/3/2026 (Estimated)NIONIO-$2.14B-$0.55N/A101.80N/A-8.78%-318.96%-7.67%9/1/2026 (Estimated)TWLOTwilio$33.83M$0.64288.2750.413.681.96%4.64%3.76%8/6/2026 (Estimated)Latest NIO, TWLO, and CRSP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/22/2026Q1 2026NIONIO-$0.0750$0.0030+$0.0780-$0.03$3.69 billion$3.70 billion5/4/2026Q1 2026CRSPCRISPR Therapeutics-$1.2185-$1.28-$0.0615-$1.28$6.06 million$1.46 million4/30/2026Q1 2026TWLOTwilio$1.27$1.50+$0.23$0.57$1.34 billion$1.41 billion3/31/2026Q1 2026CRSPCRISPR TherapeuticsN/A-$1.28N/A-$1.28N/A$1.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCRSPCRISPR TherapeuticsN/AN/AN/AN/AN/ANIONION/AN/AN/AN/AN/ATWLOTwilioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRSPCRISPR Therapeutics0.3217.9717.96NIONIO1.941.010.90TWLOTwilio0.134.664.66Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRSPCRISPR Therapeutics69.20%NIONIO48.55%TWLOTwilio84.27%Insider OwnershipCompanyInsider OwnershipCRSPCRISPR Therapeutics4.10%NIONIO1.00%TWLOTwilio0.21%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRSPCRISPR Therapeutics46096.45 million92.50 millionOptionableNIONIO35,0322.48 billion2.46 billionOptionableTWLOTwilio5,587151.77 million151.46 millionOptionableNIO, TWLO, and CRSP HeadlinesRecent News About These CompaniesTwilio stock hits a wall after 31% YTD rally: Has AI optimism pushed it too far?June 22 at 6:36 PM | seekingalpha.comBrokers Suggest Investing in Twilio (TWLO): Read This Before Placing a BetJune 19, 2026 | finance.yahoo.comBrokers Suggest Investing in Twilio (TWLO): Read This Before Placing a BetJune 19, 2026 | zacks.comTwilio (TWLO) Stock Sinks As Market Gains: What You Should KnowJune 18, 2026 | finance.yahoo.comTwilio (TWLO) Stock Sinks As Market Gains: What You Should KnowJune 18, 2026 | zacks.comTwilio (NYSE:TWLO) Given Buy Rating at Rosenblatt SecuritiesJune 18, 2026 | marketbeat.comCinctive Capital Management LP Has $6.93 Million Stock Holdings in Twilio Inc. $TWLOJune 18, 2026 | marketbeat.comAtreides Management LP Lowers Stake in Twilio Inc. $TWLOJune 18, 2026 | marketbeat.comBeaconlight Capital LLC Has $6.55 Million Stock Position in Twilio Inc. $TWLOJune 18, 2026 | marketbeat.comTwilio Target of Unusually Large Options Trading (NYSE:TWLO)June 18, 2026 | americanbankingnews.comArdsley Advisory Partners LP Buys New Stake in Twilio Inc. $TWLOJune 18, 2026 | marketbeat.comAlta Park Capital LP Has $19.98 Million Position in Twilio Inc. $TWLOJune 18, 2026 | marketbeat.comTwilio Shareholders Approve Governance, Compensation and Equity PlansJune 17, 2026 | tipranks.comMelqart Asset Management UK Ltd Purchases Shares of 40,447 Twilio Inc. $TWLOJune 17, 2026 | marketbeat.comRBF Capital LLC Has $3.27 Million Stake in Twilio Inc. $TWLOJune 17, 2026 | marketbeat.comTwilio Inc. $TWLO Shares Acquired by Captrust Financial AdvisorsJune 17, 2026 | marketbeat.comFred Alger Management LLC Trims Stock Position in Twilio Inc. $TWLOJune 17, 2026 | marketbeat.comTwilio Sees Unusually Large Options Volume (NYSE:TWLO)June 16, 2026 | marketbeat.comTemasek Holdings Private Ltd Purchases Shares of 309,573 Twilio Inc. $TWLOJune 16, 2026 | marketbeat.comOccam Crest Management LP Buys 6,000 Shares of Twilio Inc. $TWLOJune 16, 2026 | marketbeat.comTwilio Inc. $TWLO Shares Bought by Panagora Asset Management Inc.June 16, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 2026Applied Digital Is Building a $36 Billion AI Real Estate EmpireBy Jeffrey Neal Johnson | June 12, 2026Can Trupanion Turn Pet Insurance Loyalty Into Real Earnings?By Peter Frank | June 18, 2026Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?By Jessica Mitacek | May 28, 20263 Stocks Diluting Shareholders to Fund Big Long-Term OpportunitiesBy Leo Miller | June 16, 2026NIO, TWLO, and CRSP Company DescriptionsCRISPR Therapeutics NASDAQ:CRSP$53.99 -0.37 (-0.68%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$54.03 +0.04 (+0.07%) As of 06/23/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.NIO NYSE:NIO$5.09 +0.04 (+0.79%) Closing price 06/23/2026 03:58 PM EasternExtended Trading$5.07 -0.02 (-0.37%) As of 06/23/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NIO Inc. designs, manufactures, and sells electric vehicles in the People's Republic of China. The company is also involved in the manufacture of e-powertrain, battery packs, and components; and racing management, technology development, and sales and after-sales management activities. In addition, it offers power solutions for battery charging needs; and other value-added services. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was founded in 2014 and is headquartered in Shanghai, the People's Republic of China.Twilio NYSE:TWLO$184.49 +0.85 (+0.46%) Closing price 06/23/2026 03:58 PM EasternExtended Trading$184.34 -0.16 (-0.08%) As of 06/23/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Twilio Inc., together with its subsidiaries, provides customer engagement platform solutions in the United States and internationally. It operates through two segments, Twilio Communications and Twilio Segment. The company provides various application programming interfaces and software solutions for communications between customers and end users, including messaging, voice, email, flex, marketing campaigns, and user identity and authentication. It also offers software products to build direct, personalized relationships with their end users, such as segment, a platform that provides tools for first-party data by unifying real-time information collected; and engage, an automation platform for the delivery of omnichannel campaigns. Twilio Inc. was incorporated in 2008 and is headquartered in San Francisco, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Apple’s Intel Deal Arrives at the Right Time for Its Stock Micron’s Sudden Plunge May Be an AI Buying Chance Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. How Does D-Wave's New Simulator Change the Quantum Computing Landscape? How Intel Is Packaging the Future of American Chips Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
